Linoj Samuel, Ph.D., D(ABMM)

Linoj Samuel, Ph.D., D(ABMM)

Henry Ford Health

Linoj Samuel, Ph.D., D(A.B.M.M.) is the Division Head for Clinical Microbiology for Henry Ford Health. In this role, he provides leadership and oversight of infectious disease diagnostics for an integrated health care network spread across five hospitals and 30+ medical centers in southeast Michigan. 

Samuel received his Ph.D. in microbiology and immunology from the University of Arizona, where he focused on the factors impacting the intracellular survival of Mycobacterium tuberculosis. He then completed the medical microbiology and public health fellowship at the University of Rochester, N.Y. He is currently Chair of the American Society for Microbiology Clinical and Public Health Microbiology Committee (CPHMC).

Samuel's research is primarily focused on novel rapid methods for diagnostics and susceptibility testing. This includes inter-disciplinary work on diagnostic stewardship to improve cost effective care and test utilization for optimal patient outcomes. He has also published on laboratory accreditation, quality improvement and metrics to identify errors in clinical microbiology laboratories and reduce the potential for patient harm. Samuel's focus also includes a body of work on the role of point-of-care testing in clinical microbiology laboratories.   

Samuel is currently Co-Chair of the Education Committee for the Pan American Society for Clinical Virology and most recently served as the Chair of the American Society for Microbiology Committee for Postgraduate Educational Programs (CPEP).